PL3326637T3 - Zastosowanie ekstraktu ze skórki mangostanu w preparatach leczniczych do leczenia chorób skóry - Google Patents

Zastosowanie ekstraktu ze skórki mangostanu w preparatach leczniczych do leczenia chorób skóry

Info

Publication number
PL3326637T3
PL3326637T3 PL16829794T PL16829794T PL3326637T3 PL 3326637 T3 PL3326637 T3 PL 3326637T3 PL 16829794 T PL16829794 T PL 16829794T PL 16829794 T PL16829794 T PL 16829794T PL 3326637 T3 PL3326637 T3 PL 3326637T3
Authority
PL
Poland
Prior art keywords
medicine
preparation
skin diseases
treating skin
rind extract
Prior art date
Application number
PL16829794T
Other languages
English (en)
Inventor
Jia-Ming Chang
Pei-Yi Tsai
Ku-cheng CHEN
Original Assignee
Xantho Biotechnology Co., Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Xantho Biotechnology Co., Ltd. filed Critical Xantho Biotechnology Co., Ltd.
Publication of PL3326637T3 publication Critical patent/PL3326637T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/38—Clusiaceae, Hypericaceae or Guttiferae (Hypericum or Mangosteen family), e.g. common St. Johnswort
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Botany (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Mycology (AREA)
  • Dermatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
PL16829794T 2015-07-24 2016-07-21 Zastosowanie ekstraktu ze skórki mangostanu w preparatach leczniczych do leczenia chorób skóry PL3326637T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CN201510441951.7A CN106361784B (zh) 2015-07-24 2015-07-24 山竹果果壳萃取物用于治疗皮肤疾病的用途
EP16829794.3A EP3326637B1 (en) 2015-07-24 2016-07-21 Use of mangosteen rind extract in preparation of medicine for treating skin diseases
PCT/CN2016/090780 WO2017016428A1 (zh) 2015-07-24 2016-07-21 山竹果果壳萃取物用于制备治疗皮肤疾病的药物的用途

Publications (1)

Publication Number Publication Date
PL3326637T3 true PL3326637T3 (pl) 2021-10-25

Family

ID=57880548

Family Applications (1)

Application Number Title Priority Date Filing Date
PL16829794T PL3326637T3 (pl) 2015-07-24 2016-07-21 Zastosowanie ekstraktu ze skórki mangostanu w preparatach leczniczych do leczenia chorób skóry

Country Status (9)

Country Link
US (1) US10383906B2 (pl)
EP (1) EP3326637B1 (pl)
JP (1) JP6836581B2 (pl)
CN (1) CN106361784B (pl)
DE (1) DE212016000151U1 (pl)
DK (1) DK3326637T3 (pl)
ES (1) ES2880432T3 (pl)
PL (1) PL3326637T3 (pl)
WO (1) WO2017016428A1 (pl)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2021066754A1 (en) * 2019-10-04 2021-04-08 Tipsurat Co., Ltd. Composition of durian and mangosteen extracts and method of preparation thereof
US20240180988A1 (en) * 2021-04-09 2024-06-06 Xantho Biotechnology Co., Ltd Use of mangosteen fruit shell extract in the preparation of a medicament for treating bedsores
US20240197803A1 (en) * 2021-11-05 2024-06-20 Xantho Biotechnology Co., Ltd Use of mangosteen fruit shell extract in the preparation of a medicament for treating psoriasis
US20240358787A1 (en) * 2022-02-18 2024-10-31 Xantho Biotechnology Co., Ltd Use of mangosteen fruit shell extract in the preparation of a medicament for promoting wound healing in diabetes
CN117298164A (zh) * 2022-06-22 2023-12-29 山酮新药开发股份有限公司 山竹果壳萃取物用于制备治疗褥疮的药物的用途
CN117427102A (zh) * 2022-07-15 2024-01-23 山酮新药开发股份有限公司 山竹果壳萃取物用于制备烧烫伤伤口治疗的药物的用途
WO2024011599A1 (en) * 2022-07-15 2024-01-18 Xantho Biotechnology Co., Ltd Use of mangosteen fruit shell extract in the preparation of a medicament for burn wound therapy
CN118975978A (zh) * 2024-10-18 2024-11-19 长春理工大学 一种负载α-倒捻子素可注射温敏水凝胶的制备方法

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3968405B2 (ja) * 1996-08-30 2007-08-29 株式会社ロッテホールディングス 抗アレルギー剤
JP2003252745A (ja) * 2002-02-28 2003-09-10 Shiseido Co Ltd マトリックスメタロプロテアーゼ（ＭＭＰｓ）阻害剤
JP5140231B2 (ja) * 2004-04-08 2013-02-06 株式会社ロッテ ＩκＢキナーゼ阻害剤
JP2008520585A (ja) * 2004-11-16 2008-06-19 ルネサンス ハーブス インコーポレイテッド ガルシニア・マンゴスタナｌ植物から導く薬剤及び治療組成物
JP2006169149A (ja) * 2004-12-15 2006-06-29 Hosoda Shc:Kk 皮膚表皮基底細胞増殖促進剤
WO2007002666A2 (en) * 2005-06-22 2007-01-04 Renaissance Herbs, Inc. Pharmaceutical and therapeutic compostions derived from garcinia mangostana l plant
CN101428046A (zh) * 2007-11-06 2009-05-13 王莉 一种新型广谱抗炎镇痛的外用药物
US20110076348A1 (en) * 2008-05-22 2011-03-31 Lotte Co., Ltd. Prophylactic and/or therapeutic agent for atopic dermatitis
JP2010018550A (ja) * 2008-07-10 2010-01-28 Shinwa Sangyo Kk 皮膚用塗布剤
CA2751227C (en) * 2009-02-02 2021-10-26 Laila Nutraceuticals Composition from sphaeranthus indicus and garcinia mangostana for the control of metabolic syndrome
KR20120027172A (ko) * 2009-03-31 2012-03-21 가부시키가이샤 롯데 피부 장해의 치료 및/또는 예방을 위한 조성물
JP2010195831A (ja) * 2010-06-12 2010-09-09 Lotte Co Ltd ＩκＢキナーゼ阻害剤
GB201019297D0 (en) * 2010-11-15 2010-12-29 Pitt Elaine Improved compositions
JP5893135B2 (ja) * 2011-06-28 2016-03-23 ビボゾーン インコーポレイテッド 多重ターゲッティングの相乗効果を誘発する有効物質の組合せ及びその用途
WO2014013727A1 (ja) * 2012-07-19 2014-01-23 株式会社ロッテ 免疫調節剤
JP6252079B2 (ja) * 2012-10-02 2017-12-27 日本新薬株式会社 線維芽細胞増殖促進剤
JP6020155B2 (ja) * 2012-12-27 2016-11-02 日本新薬株式会社 線維芽細胞増殖促進剤
CN103271956A (zh) * 2013-06-18 2013-09-04 曹绍平 山竹子提取物及其制备方法和应用
CN103385992B (zh) * 2013-07-23 2015-01-14 四川圣湖生物科技有限公司 快速清理身体代谢毒素的天然草本组合物
JP2015042970A (ja) * 2013-07-25 2015-03-05 株式会社ファンケル ガレクチン−７産生抑制剤
CN103393576B (zh) * 2013-08-07 2015-12-23 伽蓝（集团）股份有限公司 一种山竹提取物及其应用
WO2016007601A1 (en) * 2014-07-11 2016-01-14 Mary Kay Inc. Pore minimizer

Also Published As

Publication number Publication date
US10383906B2 (en) 2019-08-20
DK3326637T3 (da) 2021-07-05
EP3326637A1 (en) 2018-05-30
ES2880432T3 (es) 2021-11-24
EP3326637B1 (en) 2021-04-07
DE212016000151U1 (de) 2018-03-07
US20180200318A1 (en) 2018-07-19
WO2017016428A1 (zh) 2017-02-02
EP3326637A4 (en) 2019-01-23
JP6836581B2 (ja) 2021-03-03
CN106361784A (zh) 2017-02-01
CN106361784B (zh) 2020-08-14
JP2018520193A (ja) 2018-07-26

Similar Documents

Publication Publication Date Title
IL285179A (en) Pharmaceutical preparations containing synthetic glycans for use in the treatment of diseases of the digestive system and methods and methods for their preparation
PL3326637T3 (pl) Zastosowanie ekstraktu ze skórki mangostanu w preparatach leczniczych do leczenia chorób skóry
GB201517215D0 (en) Use of cannabinoids in the treatment of inflammatory skin diseases
IL252159A0 (en) Methods and formulations for the treatment of diseases of the blood vessels of the eye
PL3377637T3 (pl) Kompozycje do stosowania w sposobach leczenia ran, zaburzeń i chorób skóry
IL264301A (en) Treatment of Fabry disease in ert-naive and ert-experienced patients
IL251530A0 (en) Use of cannabinoids in the treatment of skeletal muscle atrophy
SMT202300250T1 (it) Trattamento della malattia di alzheimer in una particolare popolazione di pazienti
EP3169321A4 (en) Propolis and extracts thereof for the treatment of skin cancers and improvement of skin health
IL251089A0 (en) Preparations and methods for the treatment of pre-cancerous skin wounds
ZA201704726B (en) Peptides and their use in the treatment of skin
ZA201804950B (en) Indolinones compounds and their use in the treatment of fibrotic diseases
IL245738A0 (en) Oxindole derivatives, ways of their preparation and their therapeutic use in the treatment of ampk-related diseases
PT3151814T (pt) Tratamento de uma lesão da pele
PL3307277T3 (pl) Jednoniciowe oligonukleotydy do zastosowania w leczeniu zaburzeń skóry
IL264600B (en) A knife for use in medical treatment
EP3154637A4 (en) Treatment of virus-based diseases of the skin
IL249860A0 (en) Pharmaceutical preparations, methods for their preparation and their use for the treatment of cancer
PT3236967T (pt) Prevenção e tratamento de doença metastática em pacientes com cancro trombocitóticos
ZA201807325B (en) Treatment of skin lesions
EP3162377A4 (en) Use of -asarone in preparing drugs for preventing and treating alzheimer's disease
HUE061056T2 (hu) Készítmény meddõség kezelésére nõi betegnél
SMT202300271T1 (it) Formulazioni farmaceutiche di liposomi pegilati e fattori di coagulazione del sangue
GB201410869D0 (en) Novel pharmaceutical formulations and their use in the treatment of periodontal disease
IL251825A0 (en) Treatment of cancer and skin damage